Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review

Age-related macular degeneration is the leading cause of vision loss in the developed world, with the expected number of affected elderly individuals reaching 17.8 million. Antivascular endothelial growth factor (anti-VEGF) injection therapy has been instrumental in treating a disease process that w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open Ophthalmol
Autori principali: Khanna, Saira, Komati, Rahul, Eichenbaum, David A, Hariprasad, Ishani, Ciulla, Thomas A, Hariprasad, Seenu M
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936465/
https://ncbi.nlm.nih.gov/pubmed/31909196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2019-000398
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi